Guinea Pig Model for Shigellosis Vaccine Development
$106,000Y01FY2011AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
This contract supports the assessment of a guinea pig model of shigellosis for evaluation of vaccine safety and efficacy.
View original record on NIH RePORTER →